MeSH tree: D12.776.210.500
A potential treatment for glioblastoma crafted by scientists at The Wertheim UF Scripps Institute renders the deadly brain cancer newly sensitive to both radiation and chemotherapy drugs, and blocks the cancer's ability to ...
Jul 1, 2025
0
36
A powerful heat dome is trapping scorching air and humidity across the Eastern U.S., bringing life‑threatening conditions through midweek.
Jun 23, 2025
0
15
Sudden narrowing of the coronary arteries—called coronary artery spasms—can lead to chest pain (angina), heart attacks, and other serious heart problems. Now, a research group has discovered that ferulic acid, a natural compound ...
May 20, 2025
0
29
To help neurologists, clinicians and families understand the current evidence for a new gene therapy for Duchenne muscular dystrophy called delandistrogene moxeparvovec, the American Academy of Neurology (AAN) has issued ...
May 14, 2025
0
17
A new study led by researchers at the Hospital for Special Surgery (HSS) suggests that currently available therapies may help control chronic muscle inflammation in Duchenne muscular dystrophy (DMD), a severe condition that ...
Apr 30, 2025
0
16
A new paper published in Gene Therapy raises serious concerns about the effectiveness of gene therapy for Duchenne muscular dystrophy (DMD), after the treatment failed to show significant benefit in a large-scale clinical ...
Apr 8, 2025
0
30
Two common and potentially deadly heart diseases can be caused by mutations in the same gene. Surprisingly, though, these two conditions are each associated with very different clinical symptoms. Using engineered heart tissue, ...
Apr 1, 2025
0
23
A patient has died while receiving Elevidys, a gene therapy for Duchenne muscular dystrophy, marking the first known death linked to the treatment.
Mar 19, 2025
0
24
Sarepta Therapeutics said Tuesday that a patient died while taking its closely watched gene therapy for muscular dystrophy, sending company shares plummeting more than 25%.
Mar 18, 2025
0
17
Children's Mercy Kansas City has achieved a significant advancement toward the treatment of rare genetic diseases through the use of personalized antisense oligonucleotides (ASOs). This innovative approach has shown promising ...
Jan 24, 2025
0
49
